Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 242 publications
Single-Cell Atlas of Renal Cell Carcinoma Brain Metastasis Uncovers Mechanisms of Immune Dysfunction and Resistance.
Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026
Deciphering the Genomic Landscape of Renal Cell Carcinoma Brain Metastases.
Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026
Universally offered germline testing in upper tract urothelial carcinoma.
Journal: Urologic oncology
Published: April 02, 2026
Influence of body composition on the efficacy of nivolumab plus ipilimumab for metastatic clear cell renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: February 16, 2026
Sex differences in the association of emotional approach coping with stress and quality of life among patients with renal cell carcinoma.
Journal: Palliative & supportive care
Published: January 30, 2026
Explainable machine learning/artificial intelligence model for estimating postoperative survival in renal cell carcinoma brain metastasis patients.
Journal: Neuro-oncology advances
Published: December 08, 2025
Metastasis-directed Therapy With or Without Pembrolizumab for Oligometastatic Clear Cell Renal Cell Carcinoma: Pooled Analysis of Two Prospective Single-arm Phase 2 Trials.
Journal: European urology
Published: November 03, 2025
Monitoring and treatment patterns of von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
Journal: Hereditary cancer in clinical practice
Published: September 18, 2025
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
Journal: CA: a cancer journal for clinicians
Published: September 15, 2025
KIM-1 and Circulating Tumor DNA Are Prognostic Markers for Oligometastatic Clear-cell Renal Cell Carcinoma: Development of a Multivariable Prognostic Model.
Journal: European urology
Published: September 12, 2025
A multicenter randomized phase II trial of lenvatinib plus everolimus versus cabozantinib in patients with metastatic clear-cell RCC that progressed on PD-1 immune checkpoint inhibition (LenCabo).
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 05, 2025
Last Updated: 09/26/2026